Description
A nootropic agent that enhances high-affinity choline uptake; significantly improves the learning deficits in the Morris' water maze of AF64A-treated rats, do not produce any significant side effects (1-10mg/kg); orally active. Alzheimer's Disease Phase 2 Discontinued